← Browse by Condition
Medical Condition

non muscle invasive bladder cancer with carcinoma in situ

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT04752722 Phase 1, Phase 2
Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Enrollment
350 pts
Location
United States, Austr...
Sponsor
enGene, Inc.
View Trial →